🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Carlos Gomez‐Roca

Institut universitaire du cancer de Toulouse Oncopole

ORCID: 0000-0002-8043-2529

Also affiliated with Institut Claudius Regaud

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Efficacy of pembrolizumab and vorinostat combination in patients with recurrent and/or metastatic squamous cell carcinomas: a phase 2 basket trial”.

Efficacy of pembrolizumab and vorinostat combination in patients with recurrent and/or metastatic squamous cell carcinomas: a phase 2 basket trial

Nature Cancer(2025)10.1038/s43018-025-01004-2

N/A

0.241DataRank · unranked

4 citations

Bastien Cabarrou, Miguel Francisco, Frédéric Bigot, François Ghiringhelli, Damien Vansteene +37 more

Phase 1 study of the immunotoxin LMB‐100 in patients with mesothelioma and other solid tumors expressing mesothelin

Cancer(2020)10.1002/cncr.33145

N/A

0DataRank · unranked

62 citations

Christine Alewine, Idrees Mian, Anna Spreafico, Lillian L. Siu, Carlos Gomez‐Roca +13 more

PD-1 Blockade in Solid Tumors with Defects in Polymerase Epsilon

Cancer Discovery(2022)10.1158/2159-8290.cd-21-0521

N/A

0DataRank · unranked

79 citations

Ivan Bièche, Éric Pasmant, Nadim Hamzaoui, Nicolas Leulliot, Lucas Michon +51 more